PT-141
Bremelanotide — MC4R Agonist
PT-141 (Bremelanotide) is a melanocortin receptor agonist. FDA-approved as Vyleesi for a related indication; available here as a research compound.
Selective MC4R / MC3R agonism in central nervous system pathways.
For Research Use Only. Sold for in vitro laboratory research. Not for human or veterinary consumption. By purchasing, you confirm you are 21+ and a qualified research professional.
Bremelanotide — cyclic heptapeptide melanocortin receptor agonist.
Every batch of PT-141 ships with an independently conducted Certificate of Analysis by Janoshik Analytical or Bioviridian. The COA includes HPLC-MS chromatogram, mass spec confirmation, endotoxin levels, and heavy metals screening.
Batch number is printed on the vial label and included in your order confirmation email. Look it up at pepidyn.com/coa.
